| Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies M Ono, N Sahara, K Kumata, B Ji, R Ni, S Koga, DW Dickson, ... Brain 140 (3), 764-780, 2017 | 221 | 2017 |
| Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study E Rodriguez-Vieitez, R Ni, B Gulyás, M Tóth, J Häggkvist, C Halldin, ... European journal of nuclear medicine and molecular imaging 42, 1119-1132, 2015 | 140 | 2015 |
| Amyloid tracers detect multiple binding sites in Alzheimer’s disease brain tissue R Ni, PG Gillberg, A Bergfors, A Marutle, A Nordberg Brain 136 (7), 2217-2227, 2013 | 131 | 2013 |
| Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain R Ni, A Marutle, A Nordberg Journal of Alzheimer's Disease 33 (3), 841-851, 2013 | 114 | 2013 |
| PET imaging of Neuroinflammation in Alzheimer’s disease R Zhou, BIN JI, Y Kong, L Qin, W Ren, Y Guan, R Ni Frontiers in Immunology, 3750, 2021 | 95 | 2021 |
| 3H-Deprenyl and 3H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain A Marutle, PG Gillberg, A Bergfors, W Yu, R Ni, I Nennesmo, L Voytenko, ... Journal of neuroinflammation 10, 1-15, 2013 | 79 | 2013 |
| Comparative in vitro and in vivo quantifications of pathologic tau deposits and their association with neurodegeneration in tauopathy mouse models R Ni, B Ji, M Ono, N Sahara, MR Zhang, I Aoki, A Nordberg, T Suhara, ... Journal of Nuclear Medicine 59 (6), 960-966, 2018 | 67 | 2018 |
| Multi-scale optoacoustic molecular imaging of brain diseases D Razansky, J Klohs, R Ni European journal of nuclear medicine and molecular imaging 48 (13), 4152-4170, 2021 | 62 | 2021 |
| In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510 A Ishikawa, T Masaki, M Jun, M Takeharu, S Masafumi, T Hiroyuki, ... Journal of Alzheimer's disease 61 (3), 1037-1052, 2018 | 62 | 2018 |
| Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients IL Choo, R Ni, M Schöll, A Wall, O Almkvist, A Nordberg Journal of Alzheimer's Disease 33 (4), 929-939, 2013 | 62 | 2013 |
| Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer’s disease R Ni, M Rudin, J Klohs Photoacoustics 10, 38-47, 2018 | 55 | 2018 |
| Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice R Ni, Z Chen, XL Deán-Ben, FF Voigt, D Kirschenbaum, G Shi, A Villois, ... Nature Biomedical Engineering, 1-14, 2022 | 49 | 2022 |
| Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system R Ni, L Mu, S Ametamey Acta Pharmacologica Sinica 40 (3), 351-357, 2019 | 40 | 2019 |
| In vitro characterization of the regional binding distribution of amyloid PET tracer florbetaben and the glia tracers deprenyl and PK11195 in autopsy Alzheimer’s brain tissue R Ni, J Röjdner, L Voytenko, T Dyrks, A Thiele, A Marutle, A Nordberg Journal of Alzheimer's Disease 80 (4), 1723-1737, 2021 | 38 | 2021 |
| Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography P Vagenknecht, A Luzgin, M Ono, B Ji, M Higuchi, D Noain, CA Maschio, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-16, 2022 | 36 | 2022 |
| Automated registration of magnetic resonance imaging and optoacoustic tomography data for experimental studies W Ren, H Skulason, F Schlegel, M Rudin, J Klohs, R Ni Neurophotonics 6 (2), 025001-025001, 2019 | 35 | 2019 |
| fMRI reveals mitigation of cerebrovascular dysfunction by bradykinin receptors 1 and 2 inhibitor noscapine in a mouse model of cerebral amyloidosis R Ni, DR Kindler, R Waag, M Rouault, P Ravikumar, R Nitsch, M Rudin, ... Frontiers in aging neuroscience 11, 27, 2019 | 35 | 2019 |
| Noninvasive detection of acute cerebral hypoxia and subsequent matrix-metalloproteinase activity in a mouse model of cerebral ischemia using multispectral-optoacoustic-tomography R Ni, M Vaas, W Ren, J Klohs Neurophotonics 5 (1), 015005, 2018 | 35 | 2018 |
| In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice Ruiqing Ni, Alessia Villois, Xose LuisDean-Ben, Zhenyue Chen, Markus Vaas ... Photoacoustics, 2021 | 33 | 2021 |
| Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease R Ni, PG Gillberg, N Bogdanovic, M Viitanen, L Myllykangas, I Nennesmo, ... Alzheimer's & dementia 13 (4), 419-430, 2017 | 33 | 2017 |
Jan KlohsAssistant professor, University of ZurichVerified email at biomed.ee.ethz.ch
